At least 4 medtech exits were significant enough to make the cut for the top 20 venture capital-backed healthcare exits of 2014, according to research firm CB Insights.
Nevro Corp.
2014: The year of the medtech IPO | Medtech Wall Street news for the week of December 15, 2014
Year in review: 2014 was the year of the medtech IPO
MDT inks package of loans worth more than $16B to back its $43B acquisition of COV | Medtech Wall Street news for the week of November 10, 2014
Nevro closes $145m IPO
Nevro Corp. (NYSE:NVRO) today closed its initial public offering, saying it raised $144.9 million by offering 8.05 million shares at $18 apiece.
Nevro boosts IPO to $126m
Nevro Corp. today raised the stakes on its forthcoming initial public offering, saying it will offer half a million more shares at a dollar over the high end of its prior range.
Medtronic issues update on debt financing before Covidien merger | Medtech Wall Street news for the week of October 27, 2014
Nevro sets range for IPO of up to $106m
Nevro Corp. set the price range for its forthcoming initial public offering, which would raise $106.3 million at the high end of the range.
Menlo Park, Calif.-based Nevro plans to trade on the NASDAQ exchange under the symbol NVRO, according to a regulatory filing.
Nevro registers $100m IPO
Nevro Corp. said it plans to raise more than $100 million in an initial public offering of stock for its implantable spinal cord stimulation system to treat chronic pain.